Switch From 2mg Aflibercept to 8mg Aflibercept in Patients With Neovascular Age-related Macular Degeneration
Clinical trial NCT07390253 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07390253
- Sponsor
- Vienna Institute for Research in Ocular Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-09-18
- Primary completion
- 2026-02-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.